Previous Article | Next Article 
Infection and Immunity, September 1998, p. 4158-4162, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bone Resorption Caused by Three Periodontal Pathogens In Vivo
in Mice Is Mediated in Part by Prostaglandin
Yuval
Zubery,1
Colin R.
Dunstan,2
Beryl M.
Story,2
Lakshmyya
Kesavalu,1
Jeffrey L.
Ebersole,1,*
Stanley C.
Holt,3 and
Brendan
F.
Boyce2
Departments of
Periodontics,1
Pathology,2 and
Microbiology,3 University of Texas
Health Science Center at San Antonio, San Antonio, Texas 78284-7894
Received 1 December 1997/Returned for modification 2 February
1998/Accepted 10 June 1998
 |
ABSTRACT |
Gingival inflammation, bacterial infection, alveolar bone
destruction, and subsequent tooth loss are characteristic features of
periodontal disease, but the precise mechanisms of bone loss are poorly
understood. Most animal models of the disease require injury to
gingival tissues or teeth, and the effects of microorganisms are thus
complicated by host responses to tissue destruction. To determine
whether three putative periodontal pathogens, Porphyromonas gingivalis, Campylobacter rectus, and
Fusobacterium nucleatum, could cause localized bone
resorption in vivo in the absence of tissue injury, we injected live or
heat-killed preparations of these microorganisms into the subcutaneous
tissues overlying the calvaria of normal mice once daily for 6 days and
then examined the bones histologically. We found that all three
microorganisms (both live and heat killed) stimulated bone resorption
and that the strain of F. nucleatum used appeared to
be the strongest inducer of osteoclast activity. Treatment of the mice
concomitantly with indomethacin reduced but did not completely inhibit
bone resorption by these microorganisms, suggesting that their effects
were mediated, in part, by arachidonic acid metabolites (e.g.,
prostaglandins). Our findings indicate that these potential pathogens
can stimulate bone resorption locally when placed beside a bone
surface in vivo in the absence of prior tissue injury and support a
role for them in the pathogenesis of bone loss around teeth in
periodontitis.
 |
INTRODUCTION |
Periodontal disease is a common
inflammatory disorder that often leads to irreversible alveolar bone
resorption and tooth loss. It begins as a mixed bacterial infection in
the gingiva surrounding teeth (18, 34) and leads
subsequently to loss of attachment of the periodontal ligament, which
anchors teeth to the surrounding bone. Since there are minimal systemic
effects of periodontitis, it is likely that the bone and soft tissue
destruction around affected teeth results from the local release
of inflammatory mediators secondary to bacterial infection
(8, 10, 17, 21, 38). Several potential periodontal pathogens
have been studied, and of these, Porphyromonas gingivalis,
Campylobacter rectus, Actinobacillus
actinomycetemcomitans, and Fusobacterium nucleatum are considered to represent a significant portion of the
pathogenic microbiota (7, 10, 21, 40). They possess or can
induce in host cells several factors, such as lipopolysaccharide (LPS)
(37), interleukin-1 (IL-1) (9), IL-6 (28,
29), tumor necrosis factor (31), surface-associated
proteins (27), fimbriae (12), vesicles,
toxins, and enzymes (30), which are thought to cause,
directly or indirectly, irreversible loss of periodontal supportive
tissues.
We showed previously that P. gingivalis
(13) and C. rectus (14) can
cause soft tissue destruction following injection of viable bacteria
into the mid-dorsal subcutaneous (s.c.) tissue of normal mice. Others
have shown that a variety of bacterial products from some of these
microorganisms can stimulate osteoclast formation (26)
and bone resorption in organ cultures of rodent bone (17,
19, 20, 25, 38, 39). To date, however, there have been no reports
of any individual putative periodontal pathogen causing bone resorption
in an in vivo model without damage to soft tissues or bone before
the introduction of microorganisms.
To address this question, we injected potential periodontal pathogens
into the s.c. tissues overlying the calvaria of normal mice using a
model that we had developed previously to examine the in vivo effects
of potential osteoclast-stimulating factors (1, 2). We
hypothesized that this model would be amenable to evaluating
host-bacterium interactions which contribute to bone resorption
in vivo. We found that P. gingivalis, C. rectus, and F. nucleatum stimulated bone
resorption in this model and that the effects were mediated, in part,
by arachidonate metabolites.
 |
MATERIALS AND METHODS |
Animals.
Female ICR Swiss mice (Harlan Laboratories,
Indianapolis, Ind.) weighing 20 to 25 g were housed in isolator
cages in an American Association for Accreditation of Laboratory Animal
Care-accredited animal facility at the University of Texas Health
Science Center at San Antonio. Autoclaved TEKLAD chow (Sprague-Dawley
Co., Madison, Wis.) and water were provided ad libitum.
Microorganisms.
We chose to study three potential
periodontopathogenic bacteria: P. gingivalis W50
(13), C. rectus 576 (14), and
F. nucleatum T18 (16). The bacteria were
grown on prereduced Trypticase soy agar plates enriched with 5%
(vol/vol) sheep blood (ETSA) in an anaerobic chamber (85%
N2, 5% CO2, 10% H2). P. gingivalis and C. rectus were cultured for 72 h while F. nucleatum was cultured for 24 h on
these plates.
All bacterial manipulations were carried out with Coy anaerobic
chambers to ensure maximum viability. The cells were harvested aseptically with a sterile cotton applicator soaked in reduced transport fluid (RTF) (36) and immediately suspended in
RTF. A sample was diluted up to 1/1,000, the optical density was
measured at 600 nm (Beckman DV-65 spectrophotometer), and the bacterial cell concentration was determined by use of strain-specific growth curves. The stock suspension was then either diluted with RTF or
centrifuged at 7,000 × g for 6 min, and a portion of
the supernatant was removed to obtain the desired concentration.
Bacterial cell suspensions were transported in anaerobic gas-filled
vacuum vials and were used within 15 to 30 min of preparation. Previous
studies with vital dyes (15) demonstrated that >95% of
bacteria treated in this way are viable at the time of injection.
Heat-killed bacteria were prepared by placing 200 µl of bacterial
cell suspension in a sealed tube and heating it to 85°C
for 10 min.
Samples of both live and heat-killed bacterial cell
suspensions were
plated on ETSA and cultured for 24 to 72 h to
determine their
viability and/or purity.
Injection of bacterial suspensions.
Live and heat-killed
bacteria (2 × 106 to 2 × 109 in 10 µl of RTF) or RTF was injected into the s.c. tissue overlying the
parietal bone on the right side of the calvarium of mice by use of a
Hamilton (Reno, Nev.) syringe once daily for 6 days. The mice were
euthanatized 8 h after the last injection, and the calvaria
were removed for histological assessment. Based on preliminary
experiments, the number of injected bacteria needed to evoke a
resorptive response ranged from 2 × 106 to 2 × 109 for C. rectus and F. nucleatum and 2 × 107 to 2 × 109 for P. gingivalis. Generally, five mice were
used for each dose of the bacteria and three mice were used for
evaluation of the RTF control.
To determine whether any of the observed effects were prostaglandin
mediated, mice (five to nine per group) injected with
2 × 10
9 bacteria of each species were also given s.c.
injections of either
indomethacin (40 µg in phosphate-buffered saline
[PBS] three times
daily) or PBS into the flank beginning 2 h
before the first bacterial
injection and continuing until 4 h
after the last injection. This
dosage schedule has been shown to be
effective in previous studies
(
1) and was the highest dose
of indomethacin that could be
given without causing animal sickness or
death over the duration
of the experiment. None of the treated mice
exhibited general
signs of sickness during the experiment. A control
group was injected
with RTF over the calvarium and given indomethacin
s.c.
Bone histology.
The calvaria were fixed in 10%
phosphate-buffered formalin and decalcified in 14% EDTA. The anterior
half of the frontal bones and most of the occipital bones were trimmed
off, and the parietal bones were cut coronally. These half calvaria
were then embedded in paraffin with the cut edges at the bottom of the
cassettes, and four nonconsecutive levels were cut, providing eight
coronal sections through each calvarium. These sections (5 µm thick)
were stained with hematoxylin and eosin. Histomorphometric analysis of
the following variables was carried out on the two sections from each
calvarium which contained the largest number of bone marrow spaces and
thus the greatest length of bone surface available for assessment of
resorption by use of the Bioquant image analysis system (R&M
Biometrics, Nashville, Tenn.) and a digitizing tablet: total bone area
between the sagittal suture and the temporalis muscle insertion and
osteoclast number (expressed per square millimeter of total bone area)
(1). Additional sections were cut at the four levels in each
calvarium, and sections from mice treated with each type of bacterium
or vehicle were stained by the Gram stain method for the detection of
bacteria which might have survived in the soft tissue and bone.
Statistical analyses.
Statistical analyses were carried out
with Minitab (State College, Pa.) statistical software. Values for all
variables for control groups of mice were found similar by one-way
analysis of variance and were pooled for comparison with those for
treatment groups. Differences between control groups and individual
treatment groups were compared with Student's t test.
Differences between dose responses were tested by two-way
analysis of variance with dose and microorganism as the
independent variables. In groups in which values did not have a
normal distribution, the data were log transformed prior to analysis.
 |
RESULTS |
Soft tissue swelling occurred at the injection site within 24 h of the first injection and increased in size throughout the experiment in almost all of the mice injected with bacteria but not in
the controls. This finding was most pronounced in animals given the highest numbers of bacteria and was barely detectable in
those given the lowest numbers. Two mice given the highest dose of
P. gingivalis developed abscesses and ulceration of the overlying skin and were excluded from the study. No difference in the
extent of soft tissue swelling was observed between mice given live bacteria and those given heat-killed bacteria.
The mice did not display any systemic effects of the injections,
maintained normal weight and behavior, and had no evidence of spread of
infection to other sites, as determined at autopsy.
Histological examination revealed edema and a mixed inflammatory
infiltrate of variable intensity in the soft tissues overlying the
calvaria; this infiltrate consisted of polymorphonuclear leukocytes, lymphocytes, and macrophages. Microabscesses (Fig.
1) and areas of soft tissue necrosis were
evident in sections from mice given the highest numbers of bacteria,
and where the necrosis abutted the bone, there was necrosis of the
underlying periosteal cells. No bacteria were seen in Gram-stained
calvarial sections from mice with either a pronounced or a mild soft
tissue inflammatory infiltrate. Thus, we assumed that the bacteria were
removed by host cells during the 8 h between the last injection
and euthanasia.

View larger version (137K):
[in this window]
[in a new window]
|
FIG. 1.
Effects of local injections of F. nucleatum on murine calvarial bone and soft tissue. Live
F. nucleatum bacteria (2 × 107) were
injected once daily for 6 days into the s.c. tissues overlying the
calvaria of mice, and the animals were sacrificed 24 h later.
Edema and abscesses (A) developed in the soft tissue
overlying the calvarium of this mouse injected with
F. nucleatum. In addition, increased numbers of
osteoclasts (arrows) were seen inside the calvarium, and these caused
an increase in the size of the bone marrow spaces (see Fig. 2C for
comparison) due to increased endosteal bone resorption.
Hematoxylin-eosin stain was used.
|
|
Increased numbers of osteoclasts were seen inside the calvaria of mice
treated with the highest numbers of all three bacteria, and the effects
are illustrated in Fig. 2; however, the
intensity of the resorption and the numbers of osteoclasts seen varied
in response to similar numbers of injected microorganisms (Fig. 2). Thus, although each bacterial species produced a dose-dependent increase in osteoclast numbers within the calvaria (Fig.
3), within the context of the species
examined, F. nucleatum was found to be the
most potent inducer of osteoclasts and P. gingivalis
was found to be the least potent inducer. At lower doses, osteoclasts tended to be confined to the endosteal marrow surfaces, particularly in
mice given P. gingivalis (Fig. 2); at higher doses,
they were also present on the upper periosteal surface, consistent with more aggressive resorption. In many places, osteoclasts had eroded through the full thickness of the bone into the overlying periosteal tissues, particularly when the highest numbers of microorganisms were
injected. Both live and heat-killed P. gingivalis and
C. rectus were equally effective in stimulating
osteoclast production (Fig. 3). However, heat-killed F. nucleatum stimulated the production of significantly fewer
osteoclasts than live F. nucleatum. Indomethacin treatment of mice given numbers of bacteria eliciting similar levels of
bone resorption (2 × 109 for P. gingivalis and 2 × 108 for C. rectus and F. nucleatum) resulted in a significant
reduction in osteoclast numbers (Fig. 4).
The intensity and extent of the soft tissue inflammatory infiltrate,
however, were histologically similar in bacterially challenged mice
treated with indomethacin or PBS.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 2.
Effects of local injections of F. nucleatum and P. gingivalis on mouse calvaria.
Live bacteria were injected once daily for 6 days into the s.c. tissues
overlying the calvaria of mice, and the animals were sacrificed 24 h later. (A) Increased numbers of osteoclasts (arrows) were seen in the
bone marrow spaces, which were enlarged as a result of the increased
osteoclast activity in the calvarium of a mouse injected with 2 × 107 F. nucleatum bacteria. (B) In contrast,
only occasional osteoclasts (arrows) were seen in the bone marrow
spaces of the calvarium of a mouse injected with 2 × 107 P. gingivalis bacteria, and few of
these marrow spaces were enlarged. These appearances (B) are similar to
those of the calvarium of a control mouse (C) given daily injections of
the vehicle (RTF). A moderately heavy acute inflammatory infiltrate and
moderate edema are present in the soft tissues overlying the calvaria
of the mice injected with bacteria. Mild edema and a few inflammatory
cells are present in the soft tissue overlying the calvarium of the
control mouse. Hematoxylin-eosin stain was used.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of injections of live or heat-killed
bacteria on osteoclast numbers in mouse calvaria. Organisms were
injected once daily for 6 days at the doses
indicated. The mice were sacrificed 24 h later, and osteoclast numbers in decalcified calvarial sections were
counted. Values are means ± standard errors of means. *,
Significantly different from mean value for vehicle-treated (RTF) mice
(P < 0.05). #, Dose response significantly different
from that to P. gingivalis (P < 0.01).
+, Dose response significantly different from that to C. rectus (P < 0.001). $, Significantly different
from mean value for mice treated with live F. nucleatum
bacteria (P < 0.01).
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of indomethacin and live bacteria on osteoclast
numbers in mouse calvaria. Injections of indomethacin (40 µg in PBS)
were given s.c. every 8 h for 6 days, beginning 2 h before
the first bacterial injection and continuing until 4 h after the
last injection in groups of mice (n = 5 for bacteria
alone; n = 5, n = 6, and
n = 7 for indomethacin with P. gingivalis, F. nucleatum, and C. rectus, respectively; n = 8 and n = 9 for RTF alone and RTF with indomethacin, respectively). Values are
means ± standard errors of means. All values for the
bacterium-injected mice (with and without indomethacin) were
significantly different from values for the vehicle-treated (RTF) mice
(P < 0.05). *, Significantly different from values
for mice given bacteria alone (P < 0.01).
|
|
The osteoclast-stimulating effects of the bacterial injections appeared
to be confined locally to the superior part of the calvaria at the site
where the microorganisms were injected, because we saw no increase in
osteoclast numbers within the bone marrow cavities inside the temporal
bones, which are attached to the lateral borders of the parietal bones.
Injected microorganisms can spread over the surface of the parietal
bones because the skin is very loosely attached. However, firm
attachment of the temporalis muscle prevents the spread of
microorganisms to the temporal bones.
 |
DISCUSSION |
Periodontitis is an important oral infection that occurs around
the teeth of up to 40% of U.S. citizens (5) and, like
osteoporosis, is often quoted as a potentially cytokine-mediated cause
of significant bone loss. Numerous potential pathogens have been
isolated from the pockets of inflammation in the gingiva adjacent to
affected teeth of patients with periodontal disease (22),
and of these, P. gingivalis has frequently been
considered to be responsible for causing the associated bone loss in
adults (6). Surprisingly, although all three of the
potential periodontal pathogens that we chose to study stimulated bone
resorption, P. gingivalis elicited the least
osteoclast-stimulating activity in our in vivo calvarial bone
resorption model. The number of microorganisms that we injected (2 × 106 to 2 × 109) is relatively small in
comparison to the number of microorganisms required to cause soft
tissue-destructive inflammatory lesions following injection into the
flanks of normal mice (>5 × 109) (4, 13)
and is within the range of the level of colonization in the gingival
sulci of patients with periodontitis (35). Thus, the effects
that we observed on osteoclasts in the calvaria of mice in the present
study, particularly with the lower numbers of microorganisms, are
unlikely to have been due to overwhelming infection.
Increased bone resorption and localized osteolysis are
well-established features of infections occurring inside bones
(osteomyelitis) as a result of pathogenic microorganisms, such as
gram-positive staphylococci (24) and streptococci
and gram-negative Escherichia coli, Proteus spp.,
and Haemophilus influenzae (23). The
activation of osteoclasts in such infections is likely to be
mediated by cytokines and inflammatory mediators released locally by
host cells in response to bacterial cell products. It is widely
believed that similar mechanisms lead to alveolar bone loss around
affected teeth in patients with periodontitis, with the potential for
tooth loss. Gingival fibroblasts have been reported to increase
prostaglandin E2 and IL-1 production when cultured with LPS from
P. gingivalis (33), and IL-1
, tumor
necrosis factor alpha, and IL-6, which stimulate bone resorption
in vivo (3, 11, 32), are found in gingival crevicular fluid
(9, 31).
The dramatic increase in osteoclast numbers and the full-thickness
calvarial bone resorption defects that we observed in response to all
three bacteria were similar to the effects that we observed in
the calvaria of mice following local injections of IL-1
(1). In those experiments, we saw resorption defects through
the full thickness of calvarial bones 4 days after the last of three
daily injections of IL-1. This time corresponds to the day of
experiment termination following local calvarial injections of bacteria
for 6 days in the present study. The local osteoclast-stimulating effect seen 4 days after the IL-1 injections was prevented by concomitant treatment with indomethacin and thus appeared to be eicosanoid dependent (e.g., prostaglandins) (1). Treatment of mice with indomethacin in the present study significantly attenuated the increase in osteoclast numbers and activity; thus, the changes observed in the calvaria were likely to have been partly eicosanoid mediated. Although the dose of indomethacin given (40 mg three times
daily for 7 days) was less than half that which we administered previously to prevent IL-1-induced local bone resorption in mice (1), it was the highest dose that we could administer for 7 days in the present study, since higher doses (60 mg or more three times daily) caused morbidity or mortality in the mice. Thus, we
believe that the dose was sufficiently high to have reached therapeutic
levels in blood and to have accounted for the reduced bone resorption.
Our observation that preparations of heat-killed P. gingivalis and C. rectus stimulated bone
resorption to the same degree as live organisms suggests that the
effects are likely to be due either to direct stimulation of
osteoclasts by bacterial cell products or to indirect stimulation of
osteoclasts by products, such as cytokines, released locally by host
cells, rather than to the release of osteoclast-stimulating factors by
live bacteria during the infection. This observation was not uniform,
however, since live F. nucleatum elicited significantly
greater osteoclast numbers than heat-killed bacteria. The basis for
this difference is not obvious; however, it is clear that the
lipopolysaccharides of many oral microorganisms vary in their biologic
activities and are quite different from the classic LPS molecules of
the Enterobacteriaceae. We propose that heat-killed bacteria
primarily elicit host responses via LPS or heat-stable polysaccharide
components. One inference is that the LPS from F. nucleatum was less active in our model system than LPS components
from the other microorganisms examined. Our previous studies with local
calvarial injections of IL-1 (1) suggested that a cascade of
inflammatory mediators may be activated during IL-1 exposure and that
these mediators may be responsible for the subsequent dramatic
osteolytic defects. Thus, localized bacterial gingival infection could
lead to the initiation of a cascade of inflammatory events that
lead to alveolar bone loss that may or may not require the continuous
presence of live bacteria. The in vivo model described in this paper
will permit further studies with purified or partially purified
bacterial cell products and inhibitors of known cytokines to explore
the mechanisms that lead to localized tooth loss.
To our knowledge, this is the first report of bone resorption being
caused in vivo in a dose-dependent monoinfection by microorganisms which have been identified in the gingival pockets of affected teeth in
patients with periodontitis. Our findings raise the prospect that
specific antimicrobial or antiosteoclast therapy could be evaluated in
this model with the goal of preventing the establishment of bone
loss in individuals at high risk of developing periodontitis or of
abrogating the progression of the bone destruction that can
result in the loss of otherwise healthy teeth in patients with established periodontitis.
 |
ACKNOWLEDGMENTS |
This research was supported by U.S. Public Health Service
grants DE-07267 and DE-08569 from the National Institute for Dental Research.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Periodontics, School of Dentistry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX
78284-7894. Phone: (210) 567-3591. Fax: (210) 567-6858. E-mail:
EBERSOLE{at}UTHSCSA.EDU.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Boyce, B. F.,
T. B. Aufdemorte,
I. R. Garrett,
A. J. P. Yates, and G. R. Mundy.
1989.
Effects of interleukin-1 on bone turnover in normal mice.
Endocrinology
125:1142-1150[Abstract/Free Full Text].
|
| 2.
|
Boyce, B. F.,
T. Yoneda,
C. Lowe,
P. Soriano, and G. R. Mundy.
1992.
Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.
J. Clin. Invest.
90:1622-1627.
|
| 3.
|
De La Mata, J.,
H. L. Uy,
T. A. Guise,
B. Story,
B. F. Boyce,
G. R. Mundy, and G. D. Roodman.
1995.
IL-6 enhances hypercalcemia and bone resorption mediated by PTHrP in vivo.
J. Clin. Invest.
95:2846-2852.
|
| 4.
|
Ebersole, J. L.,
L. Kesavalu,
S. Schneider,
R. L. Machen, and S. C. Holt.
1995.
Comparative virulence of periodontopathogens in a mouse abscess model.
Oral Dis.
1:115-128[Medline].
|
| 5.
|
Fox, C. H.
1992.
New considerations in the prevalence of periodontal disease.
Curr. Opin. Dent.
2:5-11[Medline].
|
| 6.
|
Haffajee, A. D., and S. S. Socransky.
1994.
Microbial etiological agents of destructive periodontal diseases.
Periodontology 2000
5:78-111[Medline].
|
| 7.
|
Holt, S. C.,
J. L. Ebersole,
J. Felton,
M. Brunsvold, and K. S. Kornman.
1988.
Implantation of Bacteroides gingivalis in non-human primates initiates progression of periodontitis.
Science
239:55-57[Abstract/Free Full Text].
|
| 8.
|
Hopps, R. M., and H. J. Sismey-Durrant.
1991.
Mechanisms of alveolar bone loss in periodontal disease, p. 307-320.
In
S. Hamada, S. C. Holt, and J. R. McGhee (ed.), Periodontal disease: pathogens and host immune response. Quintessence Publishing Co., Ltd., Tokyo, Japan.
|
| 9.
|
Hou, L. T.,
C. M. Liu, and E. F. Rossomando.
1995.
Crevicular interleukin-1b in moderate and severe periodontitis patients and the effect of phase I periodontal treatment.
J. Clin. Periodontol.
22:162-167[Medline].
|
| 10.
|
Ishihara, Y.,
T. Nishihara,
E. Maki,
T. Noguchi, and T. Koga.
1991.
Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide.
J. Periodontal Res.
26:155-160[Medline].
|
| 11.
|
Johnson, R. A.,
B. F. Boyce,
G. R. Mundy, and G. D. Roodman.
1989.
Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice.
Endocrinology
124:1424-1427[Abstract/Free Full Text].
|
| 12.
|
Kawata, Y.,
S. Hanazawa,
S. Amano,
Y. Murakami,
T. Matsumoto,
K. Nishida, and S. Kitano.
1994.
Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro.
Infect. Immun.
62:3012-3016[Abstract/Free Full Text].
|
| 13.
|
Kesavalu, L.,
J. L. Ebersole,
R. L. Machen, and S. C. Holt.
1992.
Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.
Infect. Immun.
60:1455-1464[Abstract/Free Full Text].
|
| 14.
|
Kesavalu, L.,
S. C. Holt,
R. R. Crawley,
R. Borinski, and J. L. Ebersole.
1991.
Virulence of Wolinella recta in a murine abscess model.
Infect. Immun.
59:2806-2817[Abstract/Free Full Text].
|
| 15.
|
Kesavalu, L.,
S. C. Holt, and J. L. Ebersole.
1997.
Hydrolytic enzymes of Porphyromonas gingivalis: in vitro distribution and functions.
Int. J. Oral Biol.
22:255-267.
|
| 16.
|
Kinder, S., and S. C. Holt.
1989.
Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18.
Infect. Immun.
57:3425-3433[Abstract/Free Full Text].
|
| 17.
|
Kirby, A. C.,
S. Meghji,
S. P. Nair,
P. White,
K. Reddi,
T. Nishihara,
K. Nakashimi,
A. C. Willis,
R. Sim,
M. Wilson, and B. Henderson.
1995.
The potent bone-resorbing mediator of Actinobacillus actinomycetemcomitans is homologous to the molecular chaperone GroEL.
J. Clin. Invest.
96:1185-1194.
|
| 18.
|
Liakoni, H.,
P. Barber, and H. N. Newman.
1987.
Bacterial penetration of pocket soft tissues in chronic adult and juvenile periodontitis cases. An ultrastructural study.
J. Clin. Periodontol.
14:22-28[Medline].
|
| 19.
|
Meghji, S.,
B. Henderson, and M. Wilson.
1993.
Higher-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown.
J. Periodontal Res.
28:115-121[Medline].
|
| 20.
|
Meghji, S.,
M. Wilson,
L. Ivanyi, and M. Harris.
1990.
Comparison of the osteolytic activity and serum antibodies to capsules of gram negative bacteria.
J. Dent. Res.
69:980.
|
| 21.
|
Meghji, S.,
M. Wilson,
P. Barber, and B. Henderson.
1994.
Bone resorbing activity of surface-associated material of Actinobacillus actinomycetemcomitans and Eikenella corrodens.
J. Med. Microbiol.
41:197-203[Abstract/Free Full Text].
|
| 22.
|
Moore, W. E. C., and L. V. H. Moore.
1994.
The bacteria of periodontal diseases.
Periodontology 2000
5:66-77[Medline].
|
| 23.
|
Nair, S.,
S. Meghji,
M. Wilson,
K. Reddi,
P. White, and B. Henderson.
1996.
Bacterially induced bone destruction: mechanisms and misconceptions.
Infect. Immun.
64:2371-2380[Abstract].
|
| 24.
|
Nair, S.,
Y. Song,
S. Meghji,
K. Reddi,
M. Harris,
A. Ross,
S. Poole,
M. Wilson, and B. Henderson.
1995.
Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity.
J. Bone Min. Res.
10:726-734[Medline].
|
| 25.
|
Nishihara, T.,
Y. Ohsaki,
N. Ueda,
N. Saito, and G. R. Mundy.
1994.
Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.
Infect. Immun.
62:390-397[Abstract/Free Full Text].
|
| 26.
|
Nishihara, T.,
N. Ueda,
K. Amano,
Y. Ishihara,
H. Hayakawa,
T. Kuroyanagi,
Y. Ohsaki,
K. Nagata, and T. Noguchi.
1995.
Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1 production in mouse marrow cultures.
Infect. Immun.
63:1893-1898[Abstract].
|
| 27.
|
Reddi, K.,
S. Meghji,
M. Wilson, and B. Henderson.
1995.
Comparison of the osteolytic activity of surface-associated proteins of bacteria implicated in periodontal disease.
Oral Dis.
1:26-31[Medline].
|
| 28.
|
Reddi, K.,
S. Poole,
S. Nair,
S. Meghji,
B. Henderson, and M. Wilson.
1995.
Lipid A-associated proteins from periodontopathogenic bacteria induce interleukin-6 production by human gingival fibroblasts and monocytes.
FEMS Immunol. Med. Microbiol.
11:137-144[Medline].
|
| 29.
|
Reinhardt, R. A.,
M. P. Masada,
W. B. Kaldahl,
L. M. DuBois,
K. S. Kornman,
J. I. Choi,
K. L. Kalkwarf, and A. C. Allison.
1993.
Gingival fluid IL-1 and IL-6 levels in refractory periodontitis.
J. Clin. Periodontol.
20:225-331[Medline].
|
| 30.
|
Rifkin, B. R.,
A. T. Vernillo, and L. M. Golub.
1993.
Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.
J. Periodontol.
64:819-827[Medline].
|
| 31.
|
Rossomando, E. F., and L. White.
1993.
A novel method for the detection of TNF- in gingival crevicular fluid.
J. Periodontol.
64:445-449[Medline].
|
| 32.
|
Sabatini, M.,
B. F. Boyce,
T. Aufdemorte,
L. Bonewald, and G. R. Mundy.
1988.
Infusions of recombinant human interleukins 1 and 1 cause hypercalcemia in normal mice.
Proc. Natl. Acad. Sci. USA
85:5235-5239[Abstract/Free Full Text].
|
| 33.
|
Sismey-Durrant, H. J., and R. M. Hopps.
1991.
Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1- release from rat periosteal and human gingival fibroblasts in vitro.
Oral Microbiol. Immunol.
6:378-380[Medline].
|
| 34.
|
Slots, J., and R. J. Genco.
1984.
Black pigmented bacteroides species, Capnocytophaga species and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival and tissue destruction.
J. Dent. Res.
63:412-421[Free Full Text].
|
| 35.
|
Socransky, S. S.,
C. Smith,
L. Martin,
B. J. Paster,
F. E. Dewhirst, and A. E. Levin.
1994.
"Checkerboard" DNA-DNA hybridization.
BioTechniques
17:788-792[Medline].
|
| 36.
|
Syed, S. A., and W. J. Loesche.
1972.
Survival of human dental plaque flora in various transport media.
Appl. Microbiol.
24:638-644[Medline].
|
| 37.
|
Wilson, M.
1995.
Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis.
Sci. Prog.
78:19-34.
|
| 38.
|
Wilson, M.,
S. Kamin, and W. Harvey.
1985.
Bone resorbing activity of purified capsular material from Actinobacillus actinomycetemcomitans.
J. Periodontal Res.
20:484-491[Medline].
|
| 39.
|
Wilson, M.,
S. Meghji,
P. Barber, and B. Henderson.
1993.
Biological activities of surface-associated material from Porphyromonas gingivalis.
FEMS Immunol. Med. Microbiol.
6:147-155[Medline].
|
| 40.
|
Zambon, J. J.,
L. A. Christersson, and R. J. Genco.
1986.
Diagnosis and treatment of localized juvenile periodontitis.
J. Am. Dent. Assoc.
113:295-299[Abstract].
|
Infection and Immunity, September 1998, p. 4158-4162, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kuula, H., Salo, T., Pirila, E., Tuomainen, A. M., Jauhiainen, M., Uitto, V.-J., Tjaderhane, L., Pussinen, P. J., Sorsa, T.
(2009). Local and Systemic Responses in Matrix Metalloproteinase 8-Deficient Mice during Porphyromonas gingivalis-Induced Periodontitis. Infect. Immun.
77: 850-859
[Abstract]
[Full Text]
-
Behl, Y., Siqueira, M., Ortiz, J., Li, J., Desta, T., Faibish, D., Graves, D. T.
(2008). Activation of the Acquired Immune Response Reduces Coupled Bone Formation in Response to a Periodontal Pathogen. J. Immunol.
181: 8711-8718
[Abstract]
[Full Text]
-
Kesavalu, L., Sathishkumar, S., Bakthavatchalu, V., Matthews, C., Dawson, D., Steffen, M., Ebersole, J. L.
(2007). Rat Model of Polymicrobial Infection, Immunity, and Alveolar Bone Resorption in Periodontal Disease. Infect. Immun.
75: 1704-1712
[Abstract]
[Full Text]
-
Leone, C. W., Bokhadhoor, H., Kuo, D., Desta, T., Yang, J., Siqueira, M. F., Amar, S., Graves, D. T.
(2006). Immunization Enhances Inflammation and Tissue Destruction in Response to Porphyromonas gingivalis. Infect. Immun.
74: 2286-2292
[Abstract]
[Full Text]
-
Graves, D.T., Naguib, G., Lu, H., Leone, C., Hsue, H., Krall, E.
(2005). Inflammation is More Persistent in Type 1 Diabetic Mice. JDR
84: 324-328
[Abstract]
[Full Text]
-
Graves, D. T., Naguib, G., Huafei Lu, , Desta, T., Amar, S.
(2005). Porphyromonas gingivalis fimbriae are pro-inflammatory but do not play a prominent role in the innate immune response to P. gingivalis. Innate Immunity
11: 13-18
[Abstract]
-
Liu, R., Desta, T., He, H., Graves, D. T.
(2004). Diabetes Alters the Response to Bacteria by Enhancing Fibroblast Apoptosis. Endocrinology
145: 2997-3003
[Abstract]
[Full Text]
-
Choi, B.-K., Lee, H. J., Kang, J. H., Jeong, G. J., Min, C. K., Yoo, Y.-J.
(2003). Induction of Osteoclastogenesis and Matrix Metalloproteinase Expression by the Lipooligosaccharide of Treponema denticola. Infect. Immun.
71: 226-233
[Abstract]
[Full Text]
-
Jiang, Y., Mehta, C. K., Hsu, T.-Y., Alsulaimani, F. F. H.
(2002). Bacteria Induce Osteoclastogenesis via an Osteoblast-Independent Pathway. Infect. Immun.
70: 3143-3148
[Abstract]
[Full Text]
-
Graves, D.T., Oskoui, M., Voleinikova, S., Naguib, G., Cai, S., Desta, T., Kakouras, A., Jiang, Y.
(2001). Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection. JDR
80: 1875-1879
[Abstract]
-
Sakuma, Y., Tanaka, K., Suda, M., Komatsu, Y., Yasoda, A., Miura, M., Ozasa, A., Narumiya, S., Sugimoto, Y., Ichikawa, A., Ushikubi, F., Nakao, K.
(2000). Impaired Bone Resorption by Lipopolysaccharide In Vivo in Mice Deficient in the Prostaglandin E Receptor EP4 Subtype. Infect. Immun.
68: 6819-6825
[Abstract]
[Full Text]
-
Chiang, C.-Y., Kyritsis, G., Graves, D. T., Amar, S.
(1999). Interleukin-1 and Tumor Necrosis Factor Activities Partially Account for Calvarial Bone Resorption Induced by Local Injection of Lipopolysaccharide. Infect. Immun.
67: 4231-4236
[Abstract]
[Full Text]
-
Jiang, Y., Magli, L., Russo, M.
(1999). Bacterium-Dependent Induction of Cytokines in Mononuclear Cells and Their Pathologic Consequences In Vivo. Infect. Immun.
67: 2125-2130
[Abstract]
[Full Text]